Crossmark

A significant dilemma in the treatment of heart failure patients with sacubitril/valsartan or sodium-glucose co-transporter 2 inhibitors: Whether to add mineralocorticoid receptor antagonists

Crossref DOI link: https://doi.org/10.1016/j.repc.2021.10.009

Published Print: 2022-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Patoulias, Dimitrios

Papadopoulos, Christodoulos

Stavropoulos, Konstantinos

Imprialos, Konstantinos

Boulmpou, Aristi

Doumas, Michael
License Information

Text and Data Mining valid from 2022-08-01

Version of Record valid from 2022-04-30
More Information

This article is maintained by: Elsevier

Article Title: A significant dilemma in the treatment of heart failure patients with sacubitril/valsartan or sodium-glucose co-transporter 2 inhibitors: Whether to add mineralocorticoid receptor antagonists

Journal Title: Revista Portuguesa de Cardiologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.repc.2021.10.009

Content Type: simple-article

Copyright: © 2022 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below